<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7609053" created="25/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7609053</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The <term id="T1" lex="peri-kappa_B_site" sem="DNA_domain_or_region">peri-kappa B site</term> mediates <term id="T2" lex="human_immunodeficiency_virus_type_2_enhancer_activation" sem="Other"><term id="T3" lex="human_immunodeficiency_virus_type_2_enhancer" sem="DNA_domain_or_region"><term id="T4" lex="human_immunodeficiency_virus_type_2" sem="Virus">human immunodeficiency virus type 2</term> enhancer</term> activation</term> in <term id="T5" lex="monocyte" sem="Cell_natural">monocytes</term> but not in <term id="T6" lex="T_cell" sem="Cell_natural">T cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T1"/>
<clue>The peri-kappa B site <clueType>mediates</clueType> human immunodeficiency virus type 2 enhancer activation <clueLoc>in monocytes</clueLoc> but not in T cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E2">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T1"/>
<clue>The peri-kappa B site <clueType>mediates</clueType> human immunodeficiency virus type 2 enhancer activation in monocytes but <cluePolarity>not</cluePolarity> <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E29">
<type class="Positive_regulation"/>
<theme idref="T3"/>
<clue>The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer <clueType>activation</clueType> in monocytes but not in T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T7" lex="human_immunodeficiency_virus_type_2" sem="Virus">Human immunodeficiency virus type 2</term> (<term id="T8" lex="HIV-2" sem="Virus">HIV-2</term>), like <term id="T9" lex="HIV-1" sem="Virus">HIV-1</term>, causes <term id="T10" lex="AIDS" sem="Other">AIDS</term> and is associated with <term id="T11" lex="AIDS" sem="Other">AIDS</term> cases primarily in West Africa.</sentence>
<event KT="Fact" id="E3">
<type class="Biological_process"/>
<theme idref="T10"/>
<cause idref="T8"/>
<clue>Human immunodeficiency virus type 2 (HIV-2), like HIV-1, <clueType>causes</clueType> AIDS and is associated with AIDS cases primarily in West Africa.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Biological_process"/>
<theme idref="T10"/>
<cause idref="T9"/>
<clue>Human immunodeficiency virus type 2 (HIV-2), like HIV-1, <clueType>causes</clueType> AIDS and is associated with AIDS cases primarily in West Africa.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S3"><term id="T12" lex="HIV-1" sem="Virus">HIV-1</term> and <term id="T13" lex="HIV-2" sem="Virus">HIV-2</term> display significant differences in <term id="T14" lex="nucleic_acid_sequence" sem="Other">nucleic acid sequence</term> and in the natural history of clinical disease.</sentence>
<sentence id="S4">Consistent with these differences, we have previously demonstrated that the <term id="T15" lex="enhancer/promoter_region" sem="DNA_domain_or_region">enhancer/promoter region</term> of <term id="T16" lex="HIV-2" sem="Virus">HIV-2</term> functions quite differently from that of <term id="T17" lex="HIV-1" sem="Virus">HIV-1</term>.</sentence>
<sentence id="S5">Whereas activation of the <term id="T18" lex="HIV-1_enhancer" sem="DNA_domain_or_region"><term id="T19" lex="HIV-1" sem="Virus">HIV-1</term> enhancer</term> following <term id="T20" lex="T-cell_stimulation" sem="Other"><term id="A1" sem="Cell_natural">T-cell</term> stimulation</term> is mediated largely through binding of the <term id="T21" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T22" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> to two adjacent <term id="A3" sem="DNA_domain_or_region"><term id="T23" lex="kappa_B_site" sem="DNA_domain_or_region">kappa B sites</term> in the <term id="T24" lex="HIV-1_long_terminal_repeat" sem="DNA_domain_or_region"><term id="T25" lex="HIV-1" sem="Virus">HIV-1</term> long terminal repeat</term></term>, activation of the <term id="T26" lex="HIV-2_enhancer" sem="DNA_domain_or_region"><term id="T27" lex="HIV-2" sem="Virus">HIV-2</term> enhancer</term> in <term id="T28" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T29" lex="T_cell" sem="Cell_natural">T cells</term> is dependent on four <term id="T30" lex="cis-acting_element" sem="DNA_domain_or_region">cis-acting elements</term>: a single <term id="T31" lex="kappa_B_site" sem="DNA_domain_or_region">kappa B site</term>, two <term id="T32" lex="purine-rich_binding_site" sem="DNA_domain_or_region">purine-rich binding sites</term>, <term id="T33" lex="PuB1" sem="DNA_domain_or_region">PuB1</term> and <term id="T34" lex="PuB2" sem="DNA_domain_or_region">PuB2</term>, and a <term id="T35" lex="pets_site" sem="DNA_domain_or_region">pets site</term>.</sentence>
<event id="E5">
<type class="Physiological_process"/>
<theme idref="A1"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell <clueType>stimulation</clueType> is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="E5"/>
<clue>Whereas <clueType>activation</clueType> <linkTheme>of</linkTheme> the HIV-1 enhancer <linkCause>following</linkCause> T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E30">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="E7"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is <clueType>mediated</clueType> largely <linkCause>through</linkCause> binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E7">
<type class="Binding"/>
<theme idref="T22"/>
<theme idref="A3"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through <clueType>binding</clueType> <linkTheme>of</linkTheme> the transcription factor NF-kappa B <linkTheme>to</linkTheme> two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
<comment>TPS: A3</comment></event>
<event id="E8">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, <clueType>activation</clueType> <linkTheme>of</linkTheme> the HIV-2 enhancer <clueLoc>in monocytes and T cells</clueLoc> is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E9">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T31"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause>cis-acting elements</corefCause>: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E10">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T33"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause idref1="T32">cis-acting elements</corefCause>: a single kappa B site, two <corefCause idref1="T33">purine-rich binding sites</corefCause>, PuB1 and PuB2, and a pets site.</clue>
<comment>corefCause=multilayer</comment></event>
<event id="E11">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T34"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause idref1="T32">cis-acting elements</corefCause>: a single kappa B site, two <corefCause idref1="T34">purine-rich binding sites</corefCause>, PuB1 and PuB2, and a pets site.</clue>
<comment>corefCause=multilayer</comment></event>
<event id="E12">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T35"/>
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause>cis-acting elements</corefCause>: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<sentence id="S6">We have now identified a novel <term id="T36" lex="cis-acting_element" sem="DNA_family_or_group">cis-acting element</term> within the <term id="T37" lex="HIV-2_enhancer" sem="DNA_domain_or_region"><term id="T38" lex="HIV-2" sem="Virus">HIV-2</term> enhancer</term>, immediately upstream of the <term id="T39" lex="kappa_B_site" sem="DNA_domain_or_region">kappa B site</term>, designated <term id="T40" lex="peri-kappa_B" sem="DNA_domain_or_region">peri-kappa B</term>.</sentence>
<sentence id="S7">This site is conserved among isolates of <term id="T41" lex="HIV-2" sem="Virus">HIV-2</term> and the closely related <term id="T42" lex="simian_immunodeficiency_virus" sem="Virus">simian immunodeficiency virus</term>, and <term id="T43" lex="transfection_assay" sem="Other">transfection assays</term> show this site to mediate <term id="T44" lex="HIV-2_enhancer_activation" sem="Other"><term id="T45" lex="HIV-2_enhancer" sem="DNA_domain_or_region"><term id="T46" lex="HIV-2" sem="Virus">HIV-2</term> enhancer</term> activation</term> following stimulation of <term id="T47" lex="monocytic_cell_line" sem="Cell_cultured">monocytic</term> but not <term id="T48" lex="T-cell_line" sem="Cell_cultured">T-cell lines</term>.</sentence>
<event KT="Analysis" id="E13">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T40"/>
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and <clueExperiment>transfection assays</clueExperiment> <clueKT>show</clueKT> <corefCause>this site</corefCause> to <clueType>mediate</clueType> HIV-2 enhancer activation following stimulation of monocytic but not T-cell lines.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E14">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T40"/>
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and <clueExperiment>transfection assays</clueExperiment> <clueKT>show</clueKT> <corefCause>this site</corefCause> to <clueType>mediate</clueType> HIV-2 enhancer activation following stimulation of monocytic but <cluePolarity>not</cluePolarity> T-cell lines.</clue>
</event>
<event KT="Other" id="E15">
<type class="Physiological_process"/>
<theme idref="T47"/>
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer activation following <clueType>stimulation</clueType> <linkTheme>of</linkTheme> monocytic but not T-cell lines.</clue>
</event>
<event KT="Other" id="E16">
<type class="Physiological_process"/>
<theme idref="T48"/>
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer activation following <clueType>stimulation</clueType> <linkTheme>of</linkTheme> monocytic but not T-cell lines.</clue>
</event>
<event KT="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<cause idref="E15"/>
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer <clueType>activation</clueType> <linkCause>following</linkCause> stimulation of monocytic but not T-cell lines.</clue>
</event>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<cause idref="E16"/>
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer <clueType>activation</clueType> <linkCause>following</linkCause> stimulation of monocytic but not T-cell lines.</clue>
</event>
<sentence id="S8">This is the first description of an <term id="T49" lex="HIV-2_enhancer_element" sem="DNA_domain_or_region"><term id="T50" lex="HIV-2" sem="Virus">HIV-2</term> enhancer element</term> which displays such monocyte specificity, and no comparable <term id="T51" lex="enhancer_element" sem="DNA_domain_or_region">enhancer element</term> has been clearly defined for <term id="T52" lex="HIV-1" sem="Virus">HIV-1</term>.</sentence>
<sentence id="S9">While a <term id="T53" lex="nuclear_factor" sem="Protein_family_or_group">nuclear factor</term>(s) from both <term id="T54" lex="peripheral_blood_monocyte" sem="Cell_natural">peripheral blood <term id="T55" lex="monocyte" sem="Cell_natural">monocytes</term></term> and <term id="T56" lex="T_cell" sem="Cell_natural">T cells</term> binds the <term id="T57" lex="peri-kappa_B_site" sem="DNA_domain_or_region">peri-kappa B site</term>, <term id="T58" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term> suggest that either a different protein binds to this site in <term id="T59" lex="monocyte" sem="Cell_natural">monocytes</term> versus <term id="T60" lex="T_cell" sem="Cell_natural">T cells</term> or that the <term id="A20" sem="Protein_family_or_group">protein recognizing this <term id="T61" lex="enhancer_element" sem="DNA_domain_or_region">enhancer element</term></term> undergoes <term id="T62" lex="differential_modification" sem="Other">differential modification</term> in <term id="T63" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T64" lex="T_cell" sem="Cell_natural">T cells</term>, thus supporting the transfection data.</sentence>
<event KT="Fact" id="E19">
<type class="Binding"/>
<theme idref="T53"/>
<theme idref="T57"/>
<clue>While a nuclear factor(s) <clueLoc>from both peripheral blood monocytes and T cells</clueLoc> <clueType>binds</clueType> the peri-kappa B site, electrophoretic mobility shift assays suggest that either a different protein binds to this site in monocytes versus T cells or that the protein recognizing this enhancer element undergoes differential modification in monocytes and T cells, thus supporting the transfection data.</clue>
</event>
<event CL="L2" KT="Analysis" id="E21" uncertainty="probable">
<type class="Binding"/>
<theme idref="T53"/>
<theme idref="T57"/>
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, <clueExperiment>electrophoretic mobility shift assays</clueExperiment> <clueKT><clueCL>suggest</clueCL></clueKT> that either a different <corefTheme idref1="T53">protein</corefTheme> <clueType>binds</clueType> <linkTheme>to</linkTheme> <corefTheme idref1="T57">this site</corefTheme> <clueLoc>in monocytes versus T cells</clueLoc> or that the protein recognizing this enhancer element undergoes differential modification in monocytes and T cells, thus supporting the transfection data.</clue>
</event>
<event KT="Other" id="E22">
<type class="Binding"/>
<theme idref="T53"/>
<theme idref="T57"/>
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, electrophoretic mobility shift assays suggest that either a different protein binds to this site in monocytes versus T cells or that <corefTheme idref1="T53">the protein</corefTheme> <clueType>recognizing</clueType> <corefTheme idref1="T57">this enhancer element</corefTheme> undergoes differential modification in monocytes and T cells, thus supporting the transfection data.</clue>
</event>
<event CL="L2" KT="Analysis" id="E23" uncertainty="probable">
<type class="Protein_modification"/>
<theme idref="A20"/>
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, <clueExperiment>electrophoretic mobility shift assays</clueExperiment> <clueKT><clueCL>suggest</clueCL></clueKT> that either a different protein binds to this site in monocytes versus T cells or that the protein recognizing this enhancer element <linkTheme>undergoes</linkTheme> <clueType>differential modification</clueType> <clueLoc>in monocytes</clueLoc> and T cells, thus supporting the transfection data.</clue>
<comment>TPS: A20</comment></event>
<event CL="L2" KT="Analysis" id="E20">
<type class="Protein_modification"/>
<theme idref="A20"/>
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, <clueExperiment>electrophoretic mobility shift assays</clueExperiment> <clueKT><clueCL>suggest</clueCL></clueKT> that either a different protein binds to this site in monocytes versus T cells or that the protein recognizing this enhancer element <linkTheme>undergoes</linkTheme> <clueType>differential modification</clueType> <clueLoc>in</clueLoc> monocytes and <clueLoc>T cells</clueLoc>, thus supporting the transfection data.</clue>
<comment>TPS: A20</comment></event>
<sentence id="S10">Further, while specific constitutive binding to the <term id="T65" lex="peri-kappa_B_site" sem="DNA_domain_or_region">peri-kappa B site</term> is seen in <term id="T66" lex="monocyte" sem="Cell_natural">monocytes</term>, stimulation with <term id="T67" lex="phorbol_ester" sem="Organic_compound_other">phorbol esters</term> induces additional, specific <term id="A2" sem="Other">binding</term>.</sentence>
<event id="E24">
<type class="Binding"/>
<theme idref="T65"/>
<theme idref="T53"/>
<clue>Further, while specific constitutive <clueType>binding</clueType> <linkTheme>to</linkTheme> the peri-kappa B site is seen <clueLoc>in monocytes</clueLoc>, stimulation with phorbol esters induces additional, specific binding.</clue>
<comment>NO COREFTHEME for T53</comment></event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="E26"/>
<clue>Further, while specific constitutive binding to the peri-kappa B site is seen in monocytes, stimulation with phorbol esters <clueType>induces</clueType> additional, specific binding.</clue>
</event>
<event id="E26">
<type class="Physiological_process"/>
<theme idref="T66"/>
<cause idref="T67"/>
<clue>Further, while specific constitutive binding to the peri-kappa B site is seen in monocytes, <clueType>stimulation</clueType> <linkCause>with</linkCause> phorbol esters induces additional, specific binding.</clue>
</event>
<sentence id="S11">Understanding the <term id="T68" lex="monocyte-specific_function" sem="Other">monocyte-specific function</term> of the <term id="T69" lex="peri-kappa_B_factor" sem="Protein_molecule">peri-kappa B factor</term> may ultimately provide insight into the different role <term id="T70" lex="monocyte" sem="Cell_natural">monocytes</term> and <term id="T71" lex="T_cell" sem="Cell_natural">T cells</term> play in <term id="T72" lex="HIV_pathogenesis" sem="Other">HIV pathogenesis</term>.</sentence>
<event id="E27" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T72"/>
<cause idref="T70"/>
<clue>Understanding the monocyte-specific function of the peri-kappa B factor may ultimately provide insight into the different <clueType>role</clueType> monocytes and T cells <clueType>play</clueType> <linkTheme>in</linkTheme> HIV pathogenesis.</clue>
</event>
<event id="E28" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T72"/>
<cause idref="T71"/>
<clue>Understanding the monocyte-specific function of the peri-kappa B factor may ultimately provide insight into the different <clueType>role</clueType> monocytes and T cells <clueType>play</clueType> <linkTheme>in</linkTheme> HIV pathogenesis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
